Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lexicon for blood-based early detection and screening: BLOODPAC consensus document.
Clarke CA, Mitchell BL, Putcha G, Alme E, Bach P, Beer JP, Beer TM, Beidelschies MA, Hoyos J, Klein E, Kuhn P, Krunic N, Lang K, Lee JSH, Lopez Ramos D, Morgenstern D, Quinn E, Raymond VM, Rubinstein WS, Sanchez SA, Serra R, Stewart M, Leiman LC. Clarke CA, et al. Among authors: raymond vm. Clin Transl Sci. 2024 Sep;17(9):e70016. doi: 10.1111/cts.70016. Clin Transl Sci. 2024. PMID: 39206679 Free PMC article.
High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer.
Bessa X, Vidal J, Balboa JC, Márquez C, Duenwald S, He Y, Raymond V, Faull I, Burón A, Álvarez-Urturi C, Castells X, Bellosillo B, Montagut C. Bessa X, et al. Ann Oncol. 2023 Dec;34(12):1187-1193. doi: 10.1016/j.annonc.2023.09.3113. Epub 2023 Oct 5. Ann Oncol. 2023. PMID: 37805131 Free article.
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
Barzi A, Weipert CM, Espenschied CR, Raymond VM, Wang-Gillam A, Nezami MA, Gordon EJ, Mahadevan D, Mody K. Barzi A, et al. Among authors: raymond vm. Front Oncol. 2024 Feb 8;14:1339302. doi: 10.3389/fonc.2024.1339302. eCollection 2024. Front Oncol. 2024. PMID: 38406801 Free PMC article.
Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence.
Forbes SP, Yay Donderici E, Zhang N, Sharif B, Tremblay G, Schafer G, Raymond VM, Talasaz A, Eagle C, Das AK, Grady WM. Forbes SP, et al. Among authors: raymond vm. J Med Econ. 2024 Jan-Dec;27(1):991-1002. doi: 10.1080/13696998.2024.2382036. Epub 2024 Aug 1. J Med Econ. 2024. PMID: 39037853 Free article.
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE. Parikh AR, et al. Among authors: raymond vm. Clin Cancer Res. 2024 Jul 15;30(14):2964-2973. doi: 10.1158/1078-0432.CCR-23-3660. Clin Cancer Res. 2024. PMID: 38695832 Free PMC article.
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
Chung DC, Gray DM 2nd, Singh H, Issaka RB, Raymond VM, Eagle C, Hu S, Chudova DI, Talasaz A, Greenson JK, Sinicrope FA, Gupta S, Grady WM. Chung DC, et al. Among authors: raymond vm. N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714. N Engl J Med. 2024. PMID: 38477985
Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors.
Lapin M, Huang HJ, Chagani S, Javle M, Shroff RT, Pant S, Gouda MA, Raina A, Madwani K, Holley VR, Call SG, Dustin DJ, Lanman RB, Meric-Bernstam F, Raymond VM, Kwong LN, Janku F. Lapin M, et al. Among authors: raymond vm. JCO Precis Oncol. 2022 Feb;6:e2100197. doi: 10.1200/PO.21.00197. JCO Precis Oncol. 2022. PMID: 35171660 Free PMC article.
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
Page RD, Drusbosky LM, Dada H, Raymond VM, Daniel DB, Divers SG, Reckamp KL, Villalona-Calero MA, Dix D, Odegaard JI, Lanman RB, Papadimitrakopoulou VA, Leighl NB. Page RD, et al. Among authors: raymond vm. Clin Lung Cancer. 2022 Jan;23(1):72-81. doi: 10.1016/j.cllc.2021.10.001. Epub 2021 Oct 10. Clin Lung Cancer. 2022. PMID: 34782240 Free article.
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878).
Riess JW, Reckamp KL, Frankel P, Longmate J, Kelly KA, Gandara DR, Weipert CM, Raymond VM, Keer HN, Mack PC, Newman EM, Lara PN Jr. Riess JW, et al. Among authors: raymond vm. Clin Lung Cancer. 2021 Nov;22(6):541-548. doi: 10.1016/j.cllc.2021.05.001. Epub 2021 May 15. Clin Lung Cancer. 2021. PMID: 34140248 Free PMC article. Clinical Trial.
74 results